Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
AIDS Read ; 16(11): 602-6, 2006 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-17152648

RESUMO

A 46-year-old Hispanic male from Ecuador presented with fever, malaise, weight loss, and dyspnea. He was HIV-positive with a CD4+ cell count of 4/microL. He was hospitalized, and therapy for community-acquired pneumonia with broad-spectrum antibiotics was started. Both Histoplasma capsulatum and Cryptococcus neoformans were cultured from bronchial lavage, blood, and bone marrow specimens. Despite aggressive therapy with amphotericin B, the patient died 8 days after admission.


Assuntos
Infecções Oportunistas Relacionadas com a AIDS/microbiologia , Síndrome da Imunodeficiência Adquirida/microbiologia , Criptococose/virologia , HIV , Histoplasmose/virologia , Cryptococcus neoformans/isolamento & purificação , Histoplasma/isolamento & purificação , Humanos , Masculino , Pessoa de Meia-Idade
3.
Blood ; 99(4): 1486-8, 2002 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-11830505

RESUMO

Efforts to reduce relapse of non-Hodgkin lymphoma after autologous transplantation have included ex vivo stem cell selection and/or peritransplantation immunotherapy. The late infectious and immunologic consequences of these maneuvers are not well understood, although an increase in early cytomegaloviral disease after CD34(+) stem cell selection and an alteration in immunoglobulin and T-cell recovery after peritransplantation rituximab has been noted. We report the first 2 cases of progressive multifocal leukoencephalopathy caused by JC papovavirus after autologous peripheral blood stem cell transplantation and a case each of cytomegalovirus retinitis and pneumonitis. All 4 patients experienced significant impairment of CD4 T-cell recovery, placing them at risk for these unusual viral infections. The clustering of cases is concerning because all occurred shortly after the introduction of peritransplantation rituximab into treatment protocols (4 of 62 immunotherapy recipients compared with 0 of 276 without; z = 3.595; P <.001), although a direct association with this CD20 B-cell-directed therapy remains speculative.


Assuntos
Anticorpos Monoclonais/efeitos adversos , Antineoplásicos/efeitos adversos , Viroses/induzido quimicamente , Adulto , Idoso , Anticorpos Monoclonais/administração & dosagem , Anticorpos Monoclonais Murinos , Antineoplásicos/administração & dosagem , Infecções por Citomegalovirus/induzido quimicamente , Infecções por Citomegalovirus/etiologia , Feminino , Transplante de Células-Tronco Hematopoéticas/efeitos adversos , Humanos , Leucoencefalopatia Multifocal Progressiva/induzido quimicamente , Leucoencefalopatia Multifocal Progressiva/virologia , Linfoma/complicações , Linfoma/terapia , Masculino , Estudos Retrospectivos , Rituximab , Transplante Autólogo/efeitos adversos , Viroses/etiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...